Biotech grants in Norway
Explore Biotech grants for companies in Norway. This list brings together funding for drug discovery, diagnostics, cell and gene therapy, biomanufacturing and life-science research from Norwegian innovation agencies, research funders and foundations, international programs open to applicants in Norway, and competitions any company can enter, with the deadline, award size and eligibility on every listing. Grants aimed at Biotech in Norway come first.
Showing 73-96 of 596 grants
Clinical trials for advancing innovative interventions for neurodegenerative diseases
🇪🇺European Commission · European Union
Funds early clinical trials of safer, more effective interventions for non-rare neurodegenerative diseases.
European Partnership for Pandemic Preparedness (Phase 2)
🇪🇺European Commission · European Union
Funds the next phase of Europe’s pandemic-preparedness partnership, clinical networks and One Health research ecosystem.
Horizon Health: Antibody Therapies for Emerging Viruses
🇪🇺European Commission · European Union
Funds €9–10M projects that turn monoclonal antibodies into prevention and treatment options for one emerging virus.
Horizon Health: Cell-Free Protein Synthesis Platforms
🇪🇺European Commission · European Union
Funds €6–8M projects that make cell-free protein synthesis practical for discovering and producing peptide- and protein-based biologicals.
Horizon Health: Flavivirus Antibody Therapies
🇪🇺European Commission · European Union
Funds €9–10M projects that turn monoclonal antibodies into prevention and treatment options for one Flavivirus.
Independent Living and Inclusion for Persons with Disabilities
🇪🇺European Commission · European Union
Funds person-centred health, care and technology that help people with disabilities live independently and belong in their communities.
Innovative Antimicrobials Against Resistant Pathogens
🇪🇺European Commission · European Union
Funds antibacterial and antifungal therapies that expand treatment options against antimicrobial-resistant infections.
Innovative healthcare interventions for non-communicable diseases
🇪🇺European Commission · European Union
Funds €7–8M projects that validate innovative interventions for cardiovascular, metabolic, respiratory or kidney disease.
Novel Small-Molecule Antivirals for Epidemic-Potential Pathogens
🇪🇺European Commission · European Union
Funds small-molecule antivirals that expand preparedness and treatment options for future viral epidemics and pandemics.
Personalised approaches to reduce risks from adverse drug reactions due to multiple medications
🇪🇺European Commission · European Union
Funds safer medication management using biomarkers, clinical data and decision support.
Portable and versatile Point-of-care diagnostics
🇪🇺European Commission · European Union
Funds €5–7M projects that make point-of-care diagnostics more portable, versatile, accurate and useful in clinical practice.
Prevention and management of chronic non-communicable diseases in children and young people
🇪🇺European Commission · European Union
Funds implementation research that helps children and young people prevent and manage chronic disease equitably.
Horizon Bioeconomy: Global Circular Cooperation
🇪🇺European Commission · European Union
Funds a €3M coordination action to connect bio-based industries, international partners and policy makers around fair circular innovation.
Cancer Mission: First-in-Human Trials for Rare Cancers
🇪🇺European Commission · European Union
Funds €7–9M projects taking biomarker-guided rare-cancer treatments into first-in-human, multicentre phase 1 trials.
Cancer Mission: Functional Genomics for New Treatments
🇪🇺European Commission · European Union
Funds €7–8M projects that use functional genomics and patient data to uncover precise new targets for difficult-to-treat cancers.
Clinical Research for Common Cancers
🇪🇺European Commission · European Union
Funds €7–10M programmes that bring better cancer diagnosis and treatment trials to patients across four or more European countries.
Equitable Cancer Care Economics and Outcomes
🇪🇺European Commission · European Union
Funds three €5–7M projects that make cancer control more equitable, effective and cost-aware for patients and families.
Mission Soil and Cancer: Living Labs for Carcinogenic Contamination
🇪🇺European Commission · European Union
Funds two €12M projects using living labs to remediate carcinogenic soils and trace cancer risks through people, food, water and air.
Pre-Commercial Procurement for Cancer Care
🇪🇺European Commission · European Union
Funds €8–10M procurer consortia to bring affordable cancer technologies, devices and medicines from tender to patient benefit.
Young Cancer Survivors Quality of Life Network
🇪🇺European Commission · European Union
Funds one €3M coordination action that helps cancer charities and funders improve quality of life for young survivors across Europe.
Horizon Bio-CCU: Carbon to Products
🇪🇺European Commission · European Union
Funds two €6M projects that use biotechnology to purify captured carbon and turn it into sustainable feedstock for industrial products.
Horizon Biotech for Complex Plastic Recycling
🇪🇺European Commission · European Union
Funds two €5M projects to use biotechnology to recycle complex plastics into high-value products at pilot scale across industrial value chains.
Horizon Circular Bio-Based Value Chains
🇪🇺European Commission · European Union
Funds €6M projects that turn bio-waste and secondary raw materials into safe, circular products, materials and value chains.
Horizon Health: Bio-printing for Regenerative Medicine
🇪🇺European Commission · European Union
Funds €7–10M projects that advance living-cell bio-printing from laboratory proof toward regenerative medicine.